Greatbatch Inc. (GB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report


Greatbatch reported mixed third-quarter 2014 results. Although earnings comfortably surpassed the Zacks Consensus Estimate, revenues were in line with the same. We are particularly encouraged with the company's raised 2014 revenue and adjusted earnings per share guidance. Greatbatch continues to execute on its growth strategies via strategic investments, manufacturing efficiencies, operating cost containment and volume leverage. With the acquisition of CCC Medical Devices, Greatbatch aims at enhancing its medical device innovation efforts in the Neuromodulation space. However, the company continues to face significant foreign currency headwinds and persistent weakness in the portable medical product line, both of which may pressurize the top line. Considering these factors, we maintain our Neutral recommendation and set a price target of $51.00.


Greatbatch, Inc. (GB), headquartered in Clarence, N.Y., is a leading producer and supplier of batteries, capacitors, and components used in implantable medical devices (IMDs). The company also produces batteries for commercial and industrial applications such as oil and gas exploration, oceanographic equipment, seismic surveying equipment, and others. The National Aeronautics and Space Administration (NASA) uses Greatbatch batteries in various aspects of its aerospace programs.

Greatbatch realigned its operating segments in 2013. Its businesses are now divided into Greatbatch Medical and QiG.

The company reported total revenues of $664 million in 2013, up 2.7% year over year. Total revenues for nine months ended Oct 3, 2014 stood at $518.1 million, up 6.3% year over year.

The Greatbatch Medical segment (99.2% of total revenues in the first nine months of 2014) includes the former Implantable Medical and Electrochem Solutions segments, excluding QiG.

The larger Implantable Medical business designs and manufactures medical devices and components for the cardiac, neuromodulation, vascular and orthopaedic markets. It offers complete medical devices including design, development, manufacturing, and regulatory submission. The business also offers individual components for implantable medical devices as well as value-added assembly and design engineering services for its component products. Examples of these components include batteries, capacitors, filtered and un-filtered feedthroughs, machined components, enclosures, leads, introducers, catheters, as well as orthopaedic implants, instruments and cases and trays.

The smaller Electrochem business designs and manufactures total power solution for critical applications with market-leading original equipment manufacturers (OEMs), largely in the portable medical and energy space. Electrochem offers its customers components, consultation, design, development and testing for medical device applications in high-value markets, including those that support the transition of delivery of health care from clinical to outpatient and home settings, as well as those that enhance the quality of life for an aging population. Examples of these devices include powered surgical tools, automated external defibrillators, portable ultrasound devices, portable oxygen concentrators, and ventilators, among others. Electrochem provides cell and battery pack configurations for rechargeable and non-rechargeable battery power systems, charging and docking stations, and power supplies, for devices where failure is not an option.

Implantable Medical customers include leading OEMs, such as Biotronik, Boston Scientific, Johnson & Johnson, Medtronic, Smith & Nephew, Sorin Group, St. Jude Medical, Stryker and Zimmer. On the other hand, Electrochem's customers are primarily companies involved in demanding markets with sophisticated total power solutions needs, such as in the portable medical and energy markets. Some of Electrochem's larger OEM customers are Carefusion, Covidien, Ethicon Endo-Surgery, Halliburton, Phillips Healthcare, Physio-Control, and Weatherford International.

The QiG segment (0.8%) develops medical device systems by research and development in QiG. The segment invests in three areas - new medical device systems commercialization, collaborative programs with OEM customers, and strategic equity positions in start-up companies - to build a diversified and distinctive portfolio. The medical device systems developed by QiG are manufactured by Greatbatch Medical.

Greatbatch Inc. (GB): Read the Full Research Report
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

GREATBATCH INC (GB): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Stocks

Referenced Stocks: GB

More from

Related Videos




Most Active by Volume

  • $15.85 ▲ 2.06%
  • $112.34 ▲ 4.29%
  • $57.29 ▲ 0.28%
  • $24.57 ▲ 2.89%
  • $9.32 ▲ 1.08%
  • $103.90 ▲ 2.82%
  • $105.44 ▼ 0.33%
  • $43.36 ▲ 3.68%
As of 9/2/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by